You're dropping the context of the hard decisions nations and governments actually deal in day to day, year to year when it comes to budgets. That's why not a single country had a proper stockpile of N95 masks for a pandemic like this. That isn't an exaggeration: literally not one nation had enough of a stockpile for this scenario, that includes South Korea, Japan, China.
To say that nobody thought to do it is outlandish. As one example Congress set aside funds in 2006 to stockpile 100 million N95 masks. That's not strange, as many people were aware of the need to maintain such a stockpile. There is a big difference between being aware of the need, proposing plans and spending for it, and actually getting billions of dollars on a recurring basis to maintain the necessary proper stockpile perpetually with no event to push it with (yeah but we had a flu pandemic in 1957! try selling that premise). That's the actual reality of budgets and governments.
It's expensive to maintain a persistent minimum stockpile of 1 billion non-expired N95 masks to cover the US population and the demand the US has seen. If it's a year-long pandemic, a billion masks isn't enough. You need several billion masks in that scenario. Coming out of the great recession, that is a very hard budget decision for all nations. And the fact is, most nations can't afford to do it at all. The easy retort of course is to say, well, look at the damage from this virus compared to that cost for masks. That's purely hindsight spouting that tries to pretend a comprehensive reality doesn't exist and that people who make budgets don't have to deal with difficult decisions every single year (while not factoring in every possible bad scenario every time they make a budget).
And let's not pretend it's enough to stockpile masks, regarding spending allocations. If we're doing hindsight fantasy, let's be correct about it. You need to constantly maintain a lot of other gear and training for a pandemic, costing large sums of money. In an ideal scenario a nation the size of the US should probably have over a million ventilators stockpiled, just in case. We should probably maintain 2x or 3x the ICU capacity we have, on a persistent basis and at a large cost.
This isn't an argument against being more prepared. Of course every nation should have a vast magical stockpile of N95 masks that never depletes, even the ~140 poor nations of the world that can't afford to do it. The point is, it's difficult to convince any nation to do it at the required persistent scale, and most can't afford to do it regardless.
I think there is an alternative solution, though: Rather than maintaining a gigantic stockpile large enough to last a multi-year pandemic, it might be more efficient to maintain a modest stockpile sufficient for the breakout phase along with ready-to-deploy crash production capacity. This might be significantly cheaper.
This means that we need to ensure that we have the capacity to 100x, 1000x, 10,000x production--whatever is modeled to be enough to meet ongoing demand during a pandemic--within the time bought by drawing down the strategic reserve.
We don't need to maintain and refresh a complete stockpile of finished goods, or even a complete stockpile of production capacity (suitable factory floor space, meltblown nonwoven fabric equipment, etc.). We just need to know where such things exist that can be quickly directed to the desired use either with cooperation from the owner or with the DPA, how much exists naturally, and only if there is a deficit, to maintain a stockpile sufficient in combination with those identified supplies: Government-owned sterile factory floor space, for example, or spare production lines for meltblown nonwoven fabric.
We can even enlist private companies to maintain the stockpile for us. It makes way more sense to just subsidize e.g. 3M to have lots of extra meltblown nonwoven fabric production capacity. They are in the business, they maintain and operate the machinery and have the know-how and commercial connections to produce and distribute the material. They will have the capability to quickly respond to demand spikes if the capital requirements for increased production capacity already exist thanks to Uncle Sam's foresight.
Finally, what is maybe even more important than stockpiles or production capacity subsidies is the organization this exercise entails (knowing who makes what critical parts in the supply chain, where they are, what their production capacity is and how quickly it can grow, etc.), which gives an ability to rapidly marshal resources and eliminate inefficiencies to surge production as quickly as possible.
Unlike off-patent prescription drugs.
"Covid-19 Could Bring Generic Drug Manufacturing Back to the U.S., Analyst Writes"
https://www.barrons.com/articles/covid-19-could-bring-generi...